Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era

Fig. 3

Comparison of the predictive performance between the new model and the conventional prognostic models. a The area under curve (AUC) for 5-year overall survival (OS) prediction of the four prognostic models (the new prognostic model, IPI, R-IPI and NCCN-IPI) in the training cohort; (b) The AUC for 5-year OS prediction of the four prognostic models in the validation cohort; (c) The time-dependent AUC of the four prognostic models for predicting OS between 6 and 120 months in the training cohort; (d) The time-dependent AUC of the four prognostic models for predicting OS between 6 and 120 months in the validation cohort. IPI, International Prognostic Index; R-IPI, revised International Prognostic Index; NCCN-IPI, National Comprehensive Cancer Network International Prognostic Index

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us